Sulforaphane’s Role in Osteosarcoma Treatment: A Systematic Review and Meta-Analysis of Preclinical Studies
<b>Background/Objectives</b>: Osteosarcoma (OSA) is the most common bone cancer, characterized by rapid progression and poor prognosis. The isothiocyanate sulforaphane (SFN), has gained scientific interest because of its potent anticancer properties. The aim of this study was to conduct...
Saved in:
| Main Authors: | Polymnia Louka, Nuno Ferreira, Antonia Sophocleous |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/13/5/1048 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sulforaphane Inhibits Pancreatic Cancer PANC-1 Cell Activity through Activation of the p53 Signaling Pathway
by: Ziyi REN, et al.
Published: (2025-09-01) -
Sulforaphane Restores Mitochondrial β-Oxidation and Reduces Renal Lipid Accumulation in a Model of Releasing Unilateral Ureteral Obstruction
by: Ana Karina Aranda-Rivera, et al.
Published: (2025-02-01) -
Targeting p62 by sulforaphane promotes autolysosomal degradation of SLC7A11, inducing ferroptosis for osteosarcoma treatment
by: Qiuming Zou, et al.
Published: (2025-02-01) -
Significance of exosomes in osteosarcoma research: a systematic review and meta-analysis of a singular clinical investigation
by: Xuehong Liu, et al.
Published: (2024-11-01) -
Therapeutic potential of quercetin in depressive symptoms: a systematic review and meta-analysis of preclinical studies
by: Yang Yang, et al.
Published: (2025-07-01)